Product NDC: | 25021-400 |
Proprietary Name: | Heparin Sodium |
Non Proprietary Name: | Heparin Sodium |
Active Ingredient(s): | 1000 [USP'U]/mL & nbsp; Heparin Sodium |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-400 |
Labeler Name: | Sagent Pharmaceticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090808 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100706 |
Package NDC: | 25021-400-01 |
Package Description: | 25 VIAL in 1 CARTON (25021-400-01) > 1 mL in 1 VIAL |
NDC Code | 25021-400-01 |
Proprietary Name | Heparin Sodium |
Package Description | 25 VIAL in 1 CARTON (25021-400-01) > 1 mL in 1 VIAL |
Product NDC | 25021-400 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Heparin Sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100706 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceticals |
Substance Name | HEPARIN SODIUM |
Strength Number | 1000 |
Strength Unit | [USP'U]/mL |
Pharmaceutical Classes | Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] |